Trials / Completed
CompletedNCT00442806
Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction
A Randomized Clinical Trial of AdiPOse-derived Stem ceLLs in the Treatment of Patients With ST-elevation myOcardial Infarction - The APOLLO Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Cytori Therapeutics · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish safety and feasibility of utilizing Adipose-Derived Stem and Regenerative Cells (ADRC's) in patients who have suffered a ST-elevation acute myocardial infarction.
Detailed description
Subjects who have coronary artery disease and have suffered a ST-elevation acute myocardial infarction will be evaluated for eligibility in this study. Eligible subjects will undergo standard treatment after admission to the hospital and will then undergo liposuction under local anesthesia, after which ADRC's will be isolated from the lipoaspirate. According to randomization subjects will receive either ADRC's or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Injection of ADRC's | ADRC's are injected |
| OTHER | Injection of Placebo | Placebo is injected |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2007-03-02
- Last updated
- 2013-11-26
Locations
2 sites across 2 countries: Netherlands, Spain
Source: ClinicalTrials.gov record NCT00442806. Inclusion in this directory is not an endorsement.